PubMed Health⌕ Search

Biomedical subjects

D Rodham

Publications and source records attributed to D Rodham.

4 recordsLinked to original sources

A new method for measuring the blood volume of the rat using 113mIndium as a tracer.

A new method is described for the estimation of blood volume in the rat using 113mIndium chloride. No in vitro labelling step is necessary as the isotope binds specifically to transferrin in vivo. Under anaesthesia, an external jugular vein was cannulated for blood sampling and indium chloride injected directly into a lateral tail vein. Three blood samples of 0.2 ml were taken at short intervals and radioactivity measured under standard conditions. Blood volume was found to be 7.46 +/- 0.14 (mean +/- SEM) ml/100 g body weight. Repeating the study of 5 animals gave similar values for blood volume on the 2 occasions (7.23 +/- 0.26 and 6.95 +/- 0.23 ml/100 g, P > 0.05). The new technique was compared with established methods using 51Cr labelled red blood cells and 125Iodinated albumin. In each animal, the 113mIndium technique produced values approximately 10% higher than those obtained using the sum of plasma and red cell mass, in keeping with the known difference between whole body and large vein haematocrit (Indium, 7.20 +/- 0.19 and Iodine with Chromium, 6.40 +/- 0.34 ml/100 g). Data on blood volume determined using 125Iodine as the tracer on these same animals were identical (Indium, 7.20 +/- 0.19 and iodine, 7.16 +/- 0.34 ml/100 g). The method is simple to perform and appears to be at least as accurate and reproducible as established methods for measuring blood volume.

Animals↗

A comparison of measurements of lean body mass derived by bioelectrical impedance, skinfold thickness and total body potassium. A study in obese and non-obese normal subjects.

The measurement of body composition is an important part of metabolic and epidemiological research, but most currently available methods are complex and expensive. We have, therefore, compared measurements of fat mass (FM) and lean body mass (LBM), obtained using a commercially available bioelectrical impedance monitor (The Holtain Body Composition Monitor) (IMP), and by measuring skinfold thickness (SFT), with values obtained by measuring total body potassium (TBK). Twenty subjects, 10 with a body mass index (BMI) less than 30 (kg m-2), (non-obese) and 10 with BMI greater than or equal to 30 (obese) took part in the study. There was a strongly significant linear relationship between LBM calculated from TBK and that calculated from impedance (IMP), in both non-obese and obese groups analysed separately (non-obese: r = 0.92; p less than 0.001 and obese: r = 0.92; p less than 0.001) and together (all: r = 0.89; p less than 0.001). LBM calculated from TBK was strongly linearly correlated with values derived from SFT for non-obese (r = 0.91; p less than 0.001) but not for obese subjects. Mean values of LBM of non-obese subjects derived by each method were not significantly different (TBK: 51.3 +/- 10.40 kg; IMP: 53.18 +/- 10.37 kg; SFT: 48.87 +/- 9.48 kg), but significant differences existed when the subjects were obese (TBK: 51.86 +/- 9.65 kg; IMP: 58.69 +/- 8.55 kg; SFT: 67.61 +/- 8.14 kg; p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Anthropometry↗

Total-body potassium in insulin-dependent diabetes mellitus.

1. Total-body potassium and fat-free mass have been measured in 31 insulin-dependent diabetic patients and 31 age- and sex-matched normal volunteers. 2. Body mass index was significantly higher in the insulin-dependent diabetic patients (24.7 +/- 0.5 vs 23.3 +/- 0.4 kg/m2; P = 0.05). 3. Total-body potassium, uncorrected and corrected for weight and for fat-free mass, was not significantly different in the two groups (3281 +/- 141 mmol, 47.3 +/- 1.3 mmol/kg body weight, 60.9 +/- 1.0 mmol/kg fat-free mass, and 3315 +/- 143 mmol, 48.6 +/- 1.0 mmol/kg body weight, 60.4 +/- 0.8 mmol/kg fat-free mass, respectively, in diabetic patients and non-diabetic subjects). There was no relationship between blood glucose control, as assessed by glycated haemoglobin concentrations, and total-body potassium. 4. These results suggest, by contrast with previous reports, that in insulin-dependent diabetic patients, showing varying degrees of glycaemic control (glycated haemoglobin range 6.1-15.3%, mean 9.0%) that: (a) there is no significant abnormality of body potassium homoeostasis, and (b) there is no relation between total-body potassium and glycaemic control.

Adolescent↗